Jesse Gelsinger, 10 Years Later; Cloning for Kicks
November 19th, 2009
|
|
 |
 |
| November 19, 2009 |
|
by Osagie K. Obasogie, Bioethics Forum
Last month marked the tenth anniversary of Jesse Gelsinger's death — a powerful symbol of why researchers must do right by the subjects they depend upon and, moreover, why greater federal oversight of human research subjects is needed.
|
|
by Jesse Reynolds, GeneWatch
Cloning-based stem cell research has been more symbol than substance; more moving target than realistic goal. It has also been a monkey wrench in the gears for progressive advocates of responsible biotechnologies.
|
|
by Pete Shanks, GeneWatch
Enthusiasm for cloning animals has survived the failure of the technique to develop as once expected.
|
|
The Latest from Biopolitical Times
by Jesse Reynolds
Two controversial fertility specialists find it "shocking" and "ridiculous" that their leading industry group is discussing the codification of its nonbinding guidelines.
by Jesse Reynolds
While the expulsion of Michael Kamrava from the American Society for Reproductive Medicine is encouraging, federal oversight of the $3 billion fertility industry is still needed.
by Osagie K. Obasagie
A reality check greets British fertility researchers' claim that human womb transplants will be available in as little as two years.
by Marcy Darnovsky
A key government committee, a progressive news show, and a federal judge are all reconsidering human gene patents.
|
|
| |
|
by Osagie K. Obasogie
Prop. 69’s arrestee provision marks a radical expansion of the government’s power to indefinitely retain intimate information about citizens – many of whom may have done nothing more than be accused of committing a crime.
by Pete Shanks
The University of Akron has a policy that could require any candidate for employment to submit a DNA sample, despite the Genetic Information Non-discrimination Act.
|
|
by Jesse Reynolds
The remarkable push by UK researchers for animal-human hybrid embryos is another strange tale of science politics and science policy.
by Pete Shanks
Hwang Woo-Suk, the notorious Korean stem-cell and cloning researcher, was given a suspended two-year prison sentence and three years of probation by a Seoul court on Monday.
|
|
by Jesse Reynolds
The reining in of stem cell expectations continues.
by Osagie Obasogie
A recent study published in JAMA highlights the troublesome association between industry funding and clinical trial conclusions.
|
|
by Pete Shanks
There has been a brief flurry of discussion about future separate species of humans.
|
|
Other News
by Kevin B. O'Reilly, American Medical News
Among the American Society for Reproductive Medicine's recommendations: Physicians should warn patients about the dangers of multifetal pregnancies.
by Richard Alleyne, The Telegraph
Scientists are a step closer to producing a controversial "three parent baby" after they successfully fertilixed a human egg with two biological mothers.
by Mark Henderson, The Times (UK)
Primitive human sperm and eggs and the germ cells that make them have been created from embryonic stem cells.
|
|
| |
|
New Scientist
Egg freezing looks increasingly promising as an insurance policy for women who need or want to delay having children, according to the first systematic monitoring of the procedure.
Press Trust of India
Two doctors were sentenced to three years imprisonment by a local court in India for propagating sex determination tests.
|
|
| |
|
by Stuart Blackman, The Scientist
Ill-judged predictions and projections can be embarrassing at best and, at worst, damaging to the authority of science and science policy.
BBC News
The UK government has dropped plans to give ministers wide powers on holding innocent people's DNA data on record.
|
|
| |
|
by Amanda Gardner, HealthDay
Whether or not commercially available genetic tests actually provide any useful information remains in question.
by Robert F. Service, ScienceNOW Daily News
Complete Genomics may soon be able to sell full human genome sequences for less than $5000 apiece.
|
|
| |
|
by Katherine Harmon, Scientific American
A decision to pay for eggs for stem cell studies sparks debate.
by Andrew Pollack, New York Times
In a tacit acknowledgment that the promise of human embryonic stem cells is still far in the future, California’s stem cell research program awarded grants using mainly other, less controversial cells.
|
|
| |
|
by Kate Kelland, Reuters
The UK's Academy of Medical Sciences launched a study to look at the use of animals containing human material in scientific research.
by Karl Plume, Reuters
Government approvals of meat from cloned animals have stirred controversy about whether tinkering with nature is safe, or even ethical, prompting major food companies to swear off food products from cloned animals. But consumers are likely already eating meat and drinking milk from the offspring of clones without even knowing it.
|
|
|
|
|
|
|